Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI
Holding BCLI?
Track your performance easily

Brainstorm Cell Therapeutics (BCLI) Balance Sheet

527 Followers

Brainstorm Cell Therapeutics Balance Sheet

Brainstorm Cell Therapeutics's total assets for Q2 2024 were $5.68M, an increase of 69.74% from the previous quarter. BCLI total liabilities were $9.21M for the fiscal quarter, a 3.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 4.21M$ 8.45M$ 29.28M$ 51.26M$ 6.53M
Total Liabilities
$ 9.07M$ 11.47M$ 9.94M$ 15.79M$ 18.76M
Total Equity Gross Minority
$ -4.86M$ -3.02M$ 19.34M$ 35.46M$ -12.22M
Total Capitalization
$ -4.19M$ -349.00K$ 22.96M$ 40.03M$ -12.22M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Brainstorm Cell Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis